Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The molecular basis of von Hippel-Lindau disease.

× No keyword cloud information.

42 in total

1. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

Authors: T Shuin; K Kondo; S Torigoe; T Kishida; Y Kubota; M Hosaka; Y Nagashima; H Kitamura; F Latif; B Zbar
Journal: Cancer Res Date: 1994-06-01 Impact factor: 12.701

2. Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors: F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal: Science Date: 1993-05-28 Impact factor: 47.728

3. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors: H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal: N Engl J Med Date: 1993-11-18 Impact factor: 91.245

4. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

Authors: J M Whaley; J Naglich; L Gelbert; Y E Hsia; J M Lamiell; J S Green; D Collins; H P Neumann; J Laidlaw; F P Li
Journal: Am J Hum Genet Date: 1994-12 Impact factor: 11.025

5. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

Authors: J G Herman; F Latif; Y Weng; M I Lerman; B Zbar; S Liu; D Samid; D S Duan; J R Gnarra; W M Linehan
Journal: Proc Natl Acad Sci U S A Date: 1994-10-11 Impact factor: 11.205

6. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.

Authors: J Gao; J G Naglich; J Laidlaw; J M Whaley; B R Seizinger; N Kley
Journal: Cancer Res Date: 1995-02-15 Impact factor: 12.701

7. Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors: J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal: Nat Genet Date: 1994-05 Impact factor: 38.330

8. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

Authors: P A Crossey; F M Richards; K Foster; J S Green; A Prowse; F Latif; M I Lerman; B Zbar; N A Affara; M A Ferguson-Smith
Journal: Hum Mol Genet Date: 1994-08 Impact factor: 6.150

9. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.

Authors: H Kanno; K Kondo; S Ito; I Yamamoto; S Fujii; S Torigoe; N Sakai; M Hosaka; T Shuin; M Yao
Journal: Cancer Res Date: 1994-09-15 Impact factor: 12.701

10. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Authors: K Foster; A Prowse; A van den Berg; S Fleming; M M Hulsbeek; P A Crossey; F M Richards; P Cairns; N A Affara; M A Ferguson-Smith
Journal: Hum Mol Genet Date: 1994-12 Impact factor: 6.150

10 in total

1. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.

Authors: M Gorospe; J M Egan; B Zbar; M Lerman; L Geil; I Kuzmin; N J Holbrook
Journal: Mol Cell Biol Date: 1999-02 Impact factor: 4.272

2. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

Authors: K M Lonergan; O Iliopoulos; M Ohh; T Kamura; R C Conaway; J W Conaway; W G Kaelin
Journal: Mol Cell Biol Date: 1998-02 Impact factor: 4.272

The molecular basis of von Hippel-Lindau disease.

1. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

2. Identification of the von Hippel-Lindau disease tumor suppressor gene.

3. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

4. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.

5. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

6. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.

7. Mutations of the VHL tumour suppressor gene in renal carcinoma.

8. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.

9. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.

10. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

1. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.

2. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

3. HIF-1 modulates longevity and healthspan in a temperature-dependent manner.

4. Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma.

5. Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function.

6. Expression of the von Hippel-Lindau Tumor Suppressor Gene in Nonneoplastic and Neoplastic Lesions of the Thyroid.

7. pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation.

Review 8. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.

9. Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity.

10. Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma.